-+ 0.00%
-+ 0.00%
-+ 0.00%

SEPTERNA ANNOUNCES SELECTION OF SEP-204 AS DEVELOPMENT CANDIDATE FOR GRAVES' DISEASE AND TED AND REPORTS PRECLINICAL DATA AT THE 2026 AMERICAN THYROID ASSOCIATION ANNUAL MEETING

Reuters·11/04/2026 13:02:55

Veuillez vous connecter pour afficher les détails des actualités